山東章鼓(002598.SZ):公司的高效離心風機、真空泵等產品在提升能效、降低能耗方面表現出色
格隆匯7月18日丨山東章鼓(002598.SZ)在投資者互動平台表示,山東章鼓作為鼓風機行業的龍頭企業,其產品線廣泛,廣泛應用於多個領域,其中包括節能節水、環境保護等應用場景,公司在節能減排和綠色發展方面有着積極的投入和貢獻。公司通過技術創新和產品研發,不斷推出有利於綠色發展的產品。例如,公司的高效離心風機、真空泵等產品在提升能效、降低能耗方面表現出色,贏得了市場的廣泛認可。同時,公司還在懸浮技術等領域佈局,為電力行業的未來發展提供了新的動力。未來,山東章鼓將繼續秉承創新驅動、綠色發展的理念,加大在節能節水、環境保護、智能化改造等方面的投入和研發力度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.